Endocrinology (all articles)
Safety of bariatric surgery in patients with previous acute coronary events or heart failure: nationwide cohort study.
21 Jun, 2022 | 10:44h | UTC
Commentary on Twitter
#Bariatric surgery improves metabolic health of patients, but what are the risks if they have had MI before surgery?
National dataset matched 16000 pts??
Heart dis assoc w/? cardiac events post op, plus ?risk of SBO and stricture.#SoMe4Surgery https://t.co/iHsZiHIgdG pic.twitter.com/v2SXMpcZd3— BJS Open (@BjsOpen) June 17, 2022
M-A: Overweight/obesity in childhood and the risk of early puberty.
21 Jun, 2022 | 10:36h | UTCRelated Study: Patterns of Early Life Weight Gain and Female Onset of Puberty – Journal of the Endocrine Society
Opinion | Normalizing menopause – “Martha Hickey and colleagues argue that social and cultural attitudes contribute to the varied experience of menopause and that medicalization fuels negative perceptions”.
20 Jun, 2022 | 10:38h | UTCNormalizing menopause – The BMJ (free for a limited period)
News Release: Medicalizing menopause may be unhelpful for some women – British Medical Journal
Commentary: Menopause is not a disease. Experts call for new narrative for this natural stage of a woman’s life – CNN
Cohort Study: Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes.
20 Jun, 2022 | 10:36h | UTC
Commentary on Twitter
Still remember working on this in 2019 but it's out today!
Gamma-GT level has a strong association with mortality outcomes and could add to the prediction of CV mortality
https://t.co/0lzqGfgiGc pic.twitter.com/C8tSZLWlI2— Fred Ho (@fredho42) May 13, 2022
Under a CC BY-NC-ND 4.0 license
The clinician’s guide to prevention and treatment of osteoporosis.
20 Jun, 2022 | 01:22h | UTCThe clinician’s guide to prevention and treatment of osteoporosis – Osteoporosis International
Systematic Review: Rituximab for thyroid‐associated ophthalmopathy.
20 Jun, 2022 | 01:16h | UTCRituximab for thyroid‐associated ophthalmopathy – Cochrane Library
RCT: Effect of legumes in energy reduced dietary approaches to stop hypertension (DASH) diet on blood pressure among overweight and obese type 2 diabetic patients.
16 Jun, 2022 | 10:41h | UTC
Guideline: Management of hyperglycemia in hospitalized adult patients in non-critical care settings.
14 Jun, 2022 | 11:22h | UTCCommentary: Endocrine Society Issues New Guidelines for Hospitalized Patients With Diabetes – Clinical Advisor
Related:
Podcast: #330 Inpatient Diabetes with Dr. Dave Lieb – The Curbsiders
Review: Managing hyperglycaemia in inpatients – Clinical Medicine Journal
One in 500 men carry extra sex chromosome, putting them at higher risk of several common diseases.
13 Jun, 2022 | 10:35h | UTCNews Release: One in 500 men carry extra sex chromosome, putting them at higher risk of several common diseases – University of Cambridge
Original Study: Detection and characterization of male sex chromosome abnormalities in the UK Biobank study – Genetics in Medicine
Commentary: One in 500 men carry extra sex chromosome, research suggests – The Guardian
Commentary on Twitter
Interesting work looking at the prevalence of male sex chromosomal abnormalities in UK Biobank.
"Only 49 of 213 (23%) of men whom we identified with KS and only 1 of 143 (0.7%) with 47,XYY had a diagnosis of abnormal karyotype on their medical records or self-report." https://t.co/3VKh2rqxyn
— Veera M. Rajagopal (@doctorveera) June 11, 2022
Position Statement: Management of diabetic kidney disease.
13 Jun, 2022 | 08:09h | UTC
Review: The burden and risks of emerging complications of diabetes mellitus.
10 Jun, 2022 | 12:04h | UTCThe burden and risks of emerging complications of diabetes mellitus – Nature Reviews Endocrinology
Commentary on Twitter
New content online: The burden and risks of emerging complications of diabetes mellitus https://t.co/mWcYa7TsKz
— Nature Reviews Endocrinology (@NatureRevEndo) June 6, 2022
Guideline on management of diabetes-related foot infection.
10 Jun, 2022 | 11:51h | UTCRelated:
Consensus Statement: Dietary interventions to treat type 2 diabetes in adults with a goal of remission.
10 Jun, 2022 | 11:46h | UTCCommentary: Whole, plant-based diet most effective for type 2 diabetes remission, ACLM says – ACP Diabetes
M-A: Adverse cardiovascular events and mortality in men during testosterone treatment.
10 Jun, 2022 | 11:03h | UTCInvited Commentary: Testosterone: therapeutic or toxic for the cardiovascular health of men? – The Lancet Health Longevity
Study shows that excessively high BMI is also associated with type 1 diabetes—not just the type 2.
9 Jun, 2022 | 10:40h | UTCNews Release: Study shows that excessively high BMI is also associated with type 1 diabetes—not just the type 2 – Diabetologia
Original Article: Obesity in late adolescence and incident type 1 diabetes in young adulthood – Diabetologia
Systematic Review: Non-pharmacological interventions for the prevention of type 2 diabetes in low-income and middle-income countries.
8 Jun, 2022 | 10:55h | UTC
Cohort Study: Analysis of comorbidities, clinical outcomes, and parathyroidectomy in adults with primary hyperparathyroidism.
8 Jun, 2022 | 10:38h | UTCRelated Study: Mortality and Morbidity in Mild Primary Hyperparathyroidism: Results From a 10-Year Prospective Randomized Controlled Trial of Parathyroidectomy Versus Observation – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentary on Twitter
This national cohort study from Sweden found patients with primary hyperparathyroidism had an increased risk of fractures and cardiovascular events, and parathyroidectomy was associated with reduced risks for these outcomes. https://t.co/9dQAR9dqtk
— JAMA Network Open (@JAMANetworkOpen) June 3, 2022
Cohort Study: Incidence of new-onset type 2 diabetes after cancer.
8 Jun, 2022 | 10:35h | UTCIncidence of New-Onset Type 2 Diabetes After Cancer: A Danish Cohort Study – Diabetes Care
News Release: Cancer Increases the Risk of Developing Diabetes – University of Copenhagen
Commentaries on Twitter
We identify several cancers as risk factor for T2D with associated ↑21% risk of death as consequence. Fantastic cross-disciplinary collaboration @CASTLE_research @FessorC @FrederikPersson @NEXSKU @BiomedUCPH @ADA_DiabetesPro @Rigshospitalet @Stenodiabeteshttps://t.co/LYDsDXSGNB pic.twitter.com/PdOZffSjFf
— Lykke Sylow (@LykkeSylow) June 2, 2022
Patients with cancer are at higher risk for developing diabetes (esp patients with pancreatic cancer (HR 5.00), brain tumours (HR 1.54) and uterine cancer (HR 1.41) https://t.co/FzjepMrENA pic.twitter.com/PWDs5xsHOn
— K Pavithran (@drkpavithran) June 3, 2022
M-A: Comparative efficacy of novel antidiabetic drugs on cardiovascular and renal outcomes in patients with diabetic kidney disease.
7 Jun, 2022 | 11:25h | UTC
#ADA2022 – ADA Consensus Report | Heart Failure: An underappreciated complication of diabetes.
6 Jun, 2022 | 12:02h | UTC
#ADA2022 – RCT: Tirzepatide once weekly for the treatment of obesity.
6 Jun, 2022 | 11:59h | UTCTirzepatide Once Weekly for the Treatment of Obesity – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
SURMOUNT-1: In an RCT, adults with obesity treated with weekly tirzepatide had major weight loss over 72 weeks. #ADA2022 https://t.co/X2RrvYxzsV pic.twitter.com/X27bWp1Qod
— NEJM (@NEJM) June 4, 2022
#ADA2022 – RCT: Once-weekly dulaglutide for the treatment of youths with type 2 diabetes.
6 Jun, 2022 | 11:57h | UTCOnce-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Once Weekly Drug Helps Control Pediatric Type 2 Diabetes – American Diabetes Association
Commentary on Twitter
Trial compared once-weekly dulaglutide with placebo for glycemic control in youths with type 2 diabetes who may have been receiving metformin or basal insulin. Dulaglutide was superior at 26 weeks. #ADA2022 https://t.co/P6PubXvHOR pic.twitter.com/1JPIT5IyTe
— NEJM (@NEJM) June 4, 2022
#ADA2022 – Retrospective Cohort Study: Association of bariatric surgery with cancer risk and mortality in adults with obesity.
6 Jun, 2022 | 11:54h | UTCAssociation of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity – JAMA (free for a limited period)
Editorial: Bariatric Surgery and Cancer Risk – JAMA (free for a limited period)
News Release: Weight loss with bariatric surgery cuts the risk of developing cancer and death from cancer – Cleveland Clinic
Commentaries on Twitter
In this study, among adults with #obesity, #bariatricsurgery compared with no surgery was associated with a significantly lower incidence of obesity-associated #cancer and cancer-related mortality. https://t.co/x2gz3RUdra
— JAMA (@JAMA_current) June 3, 2022
Retrospective cohort presented at the @AmDiabetesAssn: incidence rate of 3.0 events vs 4.6 events per 1,000 person-years, resp, & a 32% reduced risk for developing obesity-related cancer following weight loss via surgery. @ClevelandClinic
https://t.co/6jLDmhgJbR @JAMA_current
— Karl Nadolsky (@DrKarlNadolsky) June 4, 2022
Consensus Statement: Effect of carbohydrate-restricted diets and intermittent fasting on obesity, type 2 diabetes mellitus, and hypertension management.
6 Jun, 2022 | 11:22h | UTC
Cohort Study: Pregnancy outcomes in young women with youth-onset type 2 diabetes.
3 Jun, 2022 | 12:00h | UTC
Commentary on Twitter
Type 2 diabetes in youth is a severe disease.
Among 260 pregnancies reported in the TODAY study, 2/3rds with complications:
?25% pregnancy loss
?33% preterm birth
?35% hypertension
?27% large infantsNew prevention/treatment desperately neededhttps://t.co/SaMXAy4Xjz
— Dr. David Ludwig (@davidludwigmd) June 2, 2022